• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白与特发性帕金森病之间的遗传关联。

Genetic association between alpha-synuclein and idiopathic Parkinson's disease.

作者信息

Kay Denise M, Factor Stewart A, Samii Ali, Higgins Donald S, Griffith Alida, Roberts John W, Leis Berta C, Nutt John G, Montimurro Jennifer S, Keefe Robert G, Atkins April J, Yearout Dora, Zabetian Cyrus P, Payami Haydeh

机构信息

New York State Department of Health, Division of Genetic Disorders, Wadsworth Center, Albany, New York 12208, USA.

出版信息

Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1222-30. doi: 10.1002/ajmg.b.30758.

DOI:10.1002/ajmg.b.30758
PMID:18404644
Abstract

Point mutations and copy number variations in SNCA, the gene encoding alpha-synuclein, cause familial Parkinson's disease (PD). A dinucleotide polymorphism (REP1) in the SNCA promoter may be a risk factor for common forms of PD. We studied 1,802 PD patients and 2,129 controls from the NeuroGenetics Research Consortium, using uniform, standardized protocols for diagnosis, subject recruitment, data collection, genotyping, and data analysis. Three common REP1 alleles (257, 259, and 261 bp, with control frequencies of 0.28, 0.65, and 0.06) and several rare alleles (combined frequency <0.01) were detected. We confirmed association of REP1 with PD risk [odds ratio (OR) = 0.86, P = 0.006 for 257-carriers; OR = 1.25, P = 0.022 for 261-carriers]. Using a normalization procedure, we showed that the 257 and 261 alleles are both independently associated with PD risk (for 257, P = 0.002 in overall data, 0.003 in non-familial PD, 0.001 in early-onset PD; for 261, P = 0.056 in overall data, 0.024 in non-familial PD, 0.052 in early-onset PD). The 257-associated risk was consistent with a dominant model [hazard ratio (HR) = 0.99, P = 0.91 for 257/257 vs. 257/X where X denotes all other common alleles; HR = 1.16, P = 0.004 for X/X vs. 257/X]. The 261-associated risk was consistent with a recessive model (HR = 1.89, P = 0.026 for 261/261 vs. 261/X; HR = 0.95, P = 0.42 for X/X vs. 261/X). Genotype-specific mean onset ages (+/-SD) ranged from 54.8 +/- 12.1 for 261/261 to 59.4 +/- 11.5 for 257/257, displaying a trend of decreasing onset age with increasing allele size (P = 0.055). Genetic variation in SNCA and its regulatory regions play an important role in both familial and sporadic PD.

摘要

编码α-突触核蛋白的基因SNCA中的点突变和拷贝数变异会导致家族性帕金森病(PD)。SNCA启动子中的二核苷酸多态性(REP1)可能是常见形式PD的一个风险因素。我们使用统一、标准化的方案进行诊断、受试者招募、数据收集、基因分型和数据分析,对神经遗传学研究联盟的1802例PD患者和2129例对照进行了研究。检测到三个常见的REP1等位基因(257、259和261bp,对照频率分别为0.28、0.65和0.06)以及几个罕见等位基因(合并频率<0.01)。我们证实了REP1与PD风险的关联[257携带者的优势比(OR)=0.86,P=0.006;261携带者的OR=1.25,P=0.022]。通过归一化程序,我们表明257和261等位基因均独立与PD风险相关(对于257,总体数据中P=0.002,非家族性PD中P=0.003,早发性PD中P=0.001;对于261,总体数据中P=0.056,非家族性PD中P=0.024,早发性PD中P=0.052)。257相关风险与显性模型一致[257/257与257/X(其中X表示所有其他常见等位基因)的风险比(HR)=0.99,P=0.91;X/X与257/X的HR=1.16,P=0.004]。261相关风险与隐性模型一致(261/261与261/X的HR=1.89,P=0.026;X/X与261/X的HR=0.95,P=0.42)。特定基因型的平均发病年龄(±标准差)范围从261/261的54.8±12.1到257/257的59.4±11.5,显示出发病年龄随等位基因大小增加而降低的趋势(P=0.055)。SNCA及其调控区域的基因变异在家族性和散发性PD中均起重要作用。

相似文献

1
Genetic association between alpha-synuclein and idiopathic Parkinson's disease.α-突触核蛋白与特发性帕金森病之间的遗传关联。
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1222-30. doi: 10.1002/ajmg.b.30758.
2
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.α-突触核蛋白基因启动子变异性与帕金森病的协同分析
JAMA. 2006 Aug 9;296(6):661-70. doi: 10.1001/jama.296.6.661.
3
Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.α-突触核蛋白多态性与萨斯喀彻温省人群的帕金森病有关。
Mov Disord. 2009 Dec 15;24(16):2411-4. doi: 10.1002/mds.22795.
4
Alpha-synuclein and familial Parkinson's disease.α-突触核蛋白与家族性帕金森病。
Mov Disord. 2009 Jun 15;24(8):1125-31. doi: 10.1002/mds.22524.
5
Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.α-突触核蛋白Rep1多态性与帕金森病的关联:Rep1对发病年龄的影响。
Mov Disord. 2006 Apr;21(4):534-9. doi: 10.1002/mds.20752.
6
SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.与帕金森病及血浆α-突触核蛋白水平相关的SNCA变异体
Arch Neurol. 2010 Nov;67(11):1350-6. doi: 10.1001/archneurol.2010.279.
7
Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.散发性疾病中的家族基因:α-突触核蛋白基因的常见变异与帕金森病相关。
Mech Ageing Dev. 2007 May-Jun;128(5-6):378-82. doi: 10.1016/j.mad.2007.04.002. Epub 2007 Apr 24.
8
Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.α-突触核蛋白、酒精使用障碍与帕金森病:一项病例对照研究。
Parkinsonism Relat Disord. 2009 Jul;15(6):430-4. doi: 10.1016/j.parkreldis.2008.11.011. Epub 2009 Feb 4.
9
SNCA REP1 and Parkinson's disease.突触核蛋白α共抑制因子1与帕金森病
Neurosci Lett. 2018 Aug 24;682:79-84. doi: 10.1016/j.neulet.2018.05.043. Epub 2018 May 30.
10
Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability.α-突触核蛋白启动子与帕金森病风险:微卫星和等位基因大小变异性
Neurosci Lett. 2003 Jan 9;336(1):70-2. doi: 10.1016/s0304-3940(02)01178-3.

引用本文的文献

1
Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression.用于预测早期帕金森病及非运动症状进展的多预测因子建模
Front Aging Neurosci. 2022 Aug 26;14:977985. doi: 10.3389/fnagi.2022.977985. eCollection 2022.
2
Psychosis in Parkinson's Disease: A Lesson from Genetics.帕金森病中的精神病:遗传学的启示。
Genes (Basel). 2022 Jun 20;13(6):1099. doi: 10.3390/genes13061099.
3
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
一项评估普拉西奈单抗治疗早期帕金森病安全性和有效性的II期研究(帕萨迪纳研究):原理、设计和基线数据
Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021.
4
A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.帕金森病中常见SNCA变异与临床异质性之间关联的系统评价。
NPJ Parkinsons Dis. 2021 Jul 1;7(1):54. doi: 10.1038/s41531-021-00196-5.
5
Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.肠道中的α-突触核蛋白作为帕金森病早期检测的潜在生物标志物。
Int J Mol Sci. 2020 Nov 17;21(22):8666. doi: 10.3390/ijms21228666.
6
Toward deciphering the mechanistic role of variations in the Rep1 repeat site in the transcription regulation of SNCA gene.针对 Rep1 重复序列位点变异在 SNCA 基因转录调控中的机制作用进行解析。
Neurogenetics. 2018 Aug;19(3):135-144. doi: 10.1007/s10048-018-0546-8. Epub 2018 May 5.
7
The genetic architecture of mitochondrial dysfunction in Parkinson's disease.帕金森病中线粒体功能障碍的遗传结构。
Cell Tissue Res. 2018 Jul;373(1):21-37. doi: 10.1007/s00441-017-2768-8. Epub 2018 Jan 25.
8
Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.SNCA基因变异与散发性帕金森病风险及临床结局:一项综述
Parkinsons Dis. 2017;2017:4318416. doi: 10.1155/2017/4318416. Epub 2017 Jul 11.
9
Structural variants in SNCA gene and the implication to synucleinopathies.SNCA基因的结构变异及其对突触核蛋白病的影响。
Curr Opin Genet Dev. 2017 Jun;44:110-116. doi: 10.1016/j.gde.2017.01.014. Epub 2017 Mar 2.
10
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.抗α-突触核蛋白单克隆抗体PRX002在健康志愿者中的首次人体评估。
Mov Disord. 2017 Feb;32(2):211-218. doi: 10.1002/mds.26878. Epub 2016 Nov 25.